Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-18-058575)

Filing Details

Accession Number:: 0001209191-18-058575
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-11-14 17:20:01
Reporting Period:: 2018-11-14

Accepted Time:: 2018-11-14 17:20:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1300699	Athenex Inc.	ATNX	Pharmaceutical Preparations (2834)	431985966

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1751011	Randoll Sze	C/O Athenex, Inc. 1001 Main Street, Suite 600 Buffalo NY 14203	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-11-14	1,000	$10.26	1,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (Right to Buy)	$17.09		2028-08-20	90,000	90,000	Direct
Common Stock	Stock Option (Right to Buy)	$17.77		2027-10-03	28,000	28,000	Direct
Common Stock	Stock Option (Right to Buy)	$17.30		2028-03-27	10,000	10,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2028-08-20	90,000	90,000	Direct
2027-10-03	28,000	28,000	Direct
2028-03-27	10,000	10,000	Direct

Footnotes

The option vests in four equal annual installments beginning on August 20, 2019.
The option vests in four equal annual installments beginning on October 3, 2018.
The option vests in four equal annual installments beginning on March 27, 2019.